Loading
CTIC Capital
  • Home
  • Team
  • Events
  • Careers
  • Press Release
  • News
  • Contact
  • Search

Recent News

  • Goldman-Backed Heart Valve Startup Is Said to Mull Hong Kong IPO August 17, 2018
  • 2018 CTIC Summer Happy Hour August 17, 2018
  • I-Mab closes one of China’s biggest-ever biotech fundraisings July 2, 2018
  • Chinese investors bet $100 million on Stealth Bio’s mitochondria tech June 29, 2018
  • C-Bridge Capital Leads Series B Round In Chinese Pharmaceutical Firm Nuance Biotech June 29, 2018

Archives

  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • February 2018
  • July 2017
  • May 2017
  • March 2017
  • January 2017
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • August 2015

Tags

AI cyber defense Gene circuits living cells machine learning MIT genomics startups
Copyright © 2016 CTIC Capital, LLC. All rights reserved.
I-Mab closes one of China’s biggest-ever biotech fundraisings I_Mab_Management_Team Venus A-valve - has been approved by China Food and Drug Administration (“CFDA”) (PRNewsfoto/Venus Medtech (Hangzhou) Inc.) Goldman-Backed Heart Valve Startup Is Said to Mull Hong Kong IPO
Scroll to top